Acute retention of urine (AUR) is a common urological emergency characterised by a sudden inability to pass urine associated with lower abdominal pain. In recent years, the natural history and incidence of AUR has become better understood, however, further research into methods to prevent it and evaluation of the impact an episode of AUR has on the patient is required. This review provides an overview of the current management of AUR in men and the impact of the condition on patients' quality of life.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Emberton M, Anson K . Acute urinary retention in men: an age old problem. BMJ 1999; 318: 921–925.
Choong S, Emberton M . Acute urinary retention. Br J Urol 2000; 85: 186–201.
Ball A, Feneley R, Abrahams P . The natural history of untreated “prostatism”. Br J Urol 1981; 53: 613–616.
Birkhoff J, Wiederhorn A, Hamilton M, Zinsser H . Natural history of benign prostatic hypertrophy and acute urinary retention. Urology 1976; 7: 48–52.
McConnell JD . The long term effects of medical therapy on the progression of BPH. Results from the MTOPS trial. J Urol 2002; 167, Abstract 1042.
Beard R, Hindley R, Borley N, Cox C The management of acute urinary retention in the South Thames Region. South Thames Health Authorities Urology Audit, 2001.
Higgins PM, Karia SJ, Mehta . The management of acute retention of urine. Br J Urol 1981; 53: 344–348.
Powell PH, Smith PJB, Feneley RCL . The identification of patients at risk from acute retention. Br J Urol 1980; 52: 520–522.
Murray K, Massey A, Feneley RCL . Acute urinary retention—a urodynamic assessment. Br J Urol 1984; 56: 468–473.
Waterhouse N et al. Urinary retention after total hip replacement. A prospective study. J Bone Joint Surg Br 1987; 69: 64–66.
Raz S, Zeigler M, Caine M . Pharmacological receptors in the prostate. Br J Urol 1973; 45: 663.
Spiro LH, Labay G, Orkin LA . Prostatic infarction. Role in acute urinary retention. Urology 1974; 3: 345–347.
Strachan JR, Corbishley CM, Shearer RJ . Post-operative retention associated with acute prostatic infarction. Br J Urol 1993; 72: 311–313.
McNeill SA et al. Serum PSA levels and histological changes associated with acute urinary retention. BJU Int 2000; 83 (Suppl 4): Abstract P65.
Zhou Y, Ling EA . Effects of acute complete outlet obstruction on the NADPH-diaphorase reactivity in the intra-mural ganglis of the guinea pig urinary bladder: light and electron microscopic studies. J Urol 1997; 158: 916–923.
Crowe R, Haven AJ, Burnstock G . Intramural neurons of the guinea pig urinary bladder: histochemical localisation of putative neurotransmitters in cultures and newborn animals. J Auton Nerv Syst 1986; 15: 319.
Abehouse BS . Infarct of the prostate. J Urol 1933; 3: 345–347.
Saboorian MH et al. Morphometric analysis of pathological specimens in men undergoing prostate surgery for acute retention or symptoms of BPH only. J Urol 1998; 159, Abstract 417.
Jacobsen SJ et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol 1997; 158: 481–487.
Pickard R et al. The management of men with acute urinary retention. Br J Urol 1998; 81: 712–720.
Meigs JB et al. Incidence rates and risk factors for acute urinary retention: the health professionals follow up study. J Urol 1999; 162: 376–382.
Roehrborn CG et al. Serum prostate-speific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. Urology 1999; 53: 473–479.
Lieber M et al. PSA is the strongest predictor of BPH related outcomes: results of a 4 year placebo controlled trial. J Urol 1998; 159: 104.
Rhodes T et al. Serum PSA levels predict acute urinary retention in 40-79 year old community men in Olmsted county. J Urol 2000; 161 (Suppl 4): Abstract 1118.
Kurita Y et al. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia. Urology 1998; 51: 595–600.
Allardice JT et al. Acute urinary retention: which catheter? Ann R Coll Surg Engl 1988; 70: 366–368.
Webb VJ, Booth CM . Cutting the cost of catheterisation for acute retention – a hospital or domiciliary procedure? Br J Urol 1995; 76: 443–445.
Horgan AF, Prasad B, Waldron DJ, O'Sullivan DC . Acute urinary retention. Comparison of supra-pubic and urethral catheterisation. Br J Urol 1992; 70: 149–151.
Ischan J, Hunt DR . Suprapubic catheters: a comparison of suprapubic versus urethral catheters in the treatment of acute urinary retention. Aust N Z Surg 1987; 57: 33–36.
Abrahams PH et al. Role of suprapubic catheterisation in the retention of urine. J R Soc Med 1980; 73: 845–848.
Patel MI, Watts W, Grant A . The optimal form of urinary drainage after acute retention of urine. Br J Urol Int 2001; 88: 26–29.
Taube M, Gajraj H . Trial without catheter following acute retention of urine. Br J Urol 1989; 63: 180–182.
Djavan B, Madersbacher S, Klinger C, Marberger M . Urodynamic assessment of patients with acute urinary retention: is treatment failure after prostatectomy predictable? J Urol 1997; 158: 1829–1833.
Kumar V, Marr C, Bhuvangiri A, Irwin P . A prospective study of conservatively managed acute urinary retention: prostate size matters. Br J Urol 2000; 86: 816–819.
McNeill AS et al. Long term follow up following presentation with first episode of acute urinary retention. J Urol 2000; 163 (Suppl 4): Abstract 1366.
Caine M, Pfau A, Perlberg S . The use of alpha-adrenergic blockers in benign prostatic obstruction. Br J Urol 1976; 48: 255–263.
De Mey . Alpha blockers for BPH: are there differences? Eur Urol 1999; 36: 52–63.
Somers WJ, Mora MJ, Mason MF, Padley RJ . The natural history of benign prostatic hypertrophy: incidence of urinary retention and significance of AUA symptom score. J Urol 1996; 155: 586A Abstract 1102.
McNeill SA et al. Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled trial. Br J Urol 1999; 84: 622–627.
Clark RV et al. Effective suppression of dihydrotestosterone (DHT) by G1198745, a novel, dual 5 alpha-reductase inhibitor. J Urol 1999; 161, Abstract 1037.
Roehrborn CG et al. Efficacy and safety of a dual inhibitor of 5 alpha reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 2002; 60: 434–441.
Andersen JT et al. Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia. Urology 1997; 49: 839–845.
Mc Connell JD et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic enlargement. New Engl J Med 1998; 338: 557–563.
Byington RP et al. Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation 1995; 92: 2419–2425.
Lepor H et al. The efficacy of terazosin, finasteride or both in benign prostatic hypertrophy. N Engl J Med 1996; 335: 533–539.
Kirby RS et al. Results of the PREDICT (prospective European doxazosin and combination therapy) trial. J Urol 1999; 161: Abstract 266.
McConnell JD . The long term effects of medical therapy on the progression of BPH. Results from the MTOPS trial. J Urol 2002; 167: Abstract 1042.
Wasson JH et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplaia. N Engl J Med 1995; 332: 75–79.
Higgins PM, French ME, Chadalavada SR . Management of acute retention of urine: a reappraisal. Br J Urol 1990; 67: 365–368.
Kabalin JN et al. Holmium: YAG laser resection of prostate (HoLRP) for patients in urinary retention. J Endourol 1997; 11: 291–293.
Isotalo T et al. A pilot study of a bioabsorbable self-reinforced poly L-lactic acid urethral stent combined with finasteride in the treatment of acute urinary retention from benign prostatic enlargement. Br J Urol Int 2000; 85: 83–86.
Makar AA, Thomas PJ, Fletcher MS, Harrison NW . Interstitial radiofrequency therapy of the prostate in the management of acute urinary retention. Br J Urol 1998; 81: 726–729.
Perry MJ et al. Thermo-expandable intraprostatic stent in bladder outlet obstruction: an 8 year study. Br J Urol Int 2002; 90: 216–223.
Ogiste JS, Cooper K, Kaplan SA . Are stents still useful therapy for benign prostatic hyperplasia? Curr Opin Urol 2003; 13: 51–57.
Reynard JM, Shearer RJ . Failure to void after transurethral resection of the prostate and mode of presentation. Urology 1999; 53: 336–339.
Modi P et al. A 23 year review of the management of acute retention of urine: progressing or regressing? Ann R Coll Surg Engl 2000; 82: 333–335.
Khoubehi B, Watkin NA, Mee AD, Ogden CW . Morbidity and the impact on daily activities associated with catheter drainage after acute urinary retention. Br J Urol Int 2000; 85: 1033–1036.
Rights and permissions
About this article
Cite this article
Thomas, K., Chow, K. & Kirby, R. Acute Urinary Retention: a review of the aetiology and management. Prostate Cancer Prostatic Dis 7, 32–37 (2004). https://doi.org/10.1038/sj.pcan.4500700
- acute urinary retention
- quality of life
- benign prostatic hyperplasia
This article is cited by
Systematic review and meta-analysis on management of acute urinary retention
Prostate Cancer and Prostatic Diseases (2015)
Acute urinary retention: Who is at risk and how best to manage it?
Current Prostate Reports (2006)
Acute urinary retention: Who is at risk and how best to manage it?
Current Urology Reports (2006)